Page last updated: 2024-11-01

nimodipine and Non-ST Elevated Myocardial Infarction

nimodipine has been researched along with Non-ST Elevated Myocardial Infarction in 1 studies

Nimodipine: A calcium channel blockader with preferential cerebrovascular activity. It has marked cerebrovascular dilating effects and lowers blood pressure.
nimodipine : A dihydropyridine that is 1,4-dihydropyridine which is substituted by methyl groups at positions 2 and 6, a (2-methoxyethoxy)carbonyl group at position 3, a m-nitrophenyl group at position 4, and an isopropoxycarbonyl group at position 5. An L-type calcium channel blocker, it acts particularly on cerebral circulation, and is used both orally and intravenously for the prevention and treatment of subarachnoid hemorrhage from ruptured intracranial aneurysm.

Non-ST Elevated Myocardial Infarction: A myocardial infarction that does not produce elevations in the ST segments of the ELECTROCARDIOGRAM. ST segment elevation of the ECG is often used in determining the treatment protocol (see also ST Elevation Myocardial Infarction).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sundararajan, K1
Roberts-Thomson, RL1
Nelson, AJ1
Psaltis, PJ1

Other Studies

1 other study available for nimodipine and Non-ST Elevated Myocardial Infarction

ArticleYear
Therapeutic paradox: nimodipine attenuates severe coronary spasm following coronary artery graft surgery in a high-risk vasoplegic cancer patient.
    Internal medicine journal, 2017, Volume: 47, Issue:2

    Topics: Colorectal Neoplasms; Coronary Angiography; Coronary Artery Bypass; Coronary Vasospasm; Coronary Ves

2017